Studies on the pharmacological properties of oxindole (2-hydroxyindole) and 5-hydroxyindole: Are they involved in hepatic encephalopathy?

Advances in Experimental Medicine and Biology

Volumn 420, Issue , 1997, Pages 57-73

  Moroni, Flavio ^a   Carpenedo, Raffaella ^a   Mannaioni, Guido ^a   Galli, Alessandro ^a   Chiarugi, Alberto ^a   Caria, Vincenzo ^a   Moneti, Gloriano ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 MERCAPTOPROPIONIC ACID; 4 AMINOBUTYRIC ACID; 5 HYDROXYINDOLE; DIAZEPAM; OXINDOLE; PICROTOXIN; STRYCHNINE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; CONFERENCE PAPER; ELECTROPHYSIOLOGY; GABAERGIC SYSTEM; HEPATIC ENCEPHALOPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ION PAIR CHROMATOGRAPHY; LIVER FAILURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TRYPTOPHAN METABOLISM;

ANIMALIA; STRYCHNOS TOXIFERA;

EID: 0030833287     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5945-0_4     Document Type: Conference Paper

References (15)

1. Basile, A.S., L. Panell, T. Jaouni, S.H. Gammal, H. Paies, E.A. Jones and P. Skolnick, 1990, Brain concentration of benzodiazepines are elevated in an animal model of hepatic encephalopathy, Proc. Natl. Acad. Sci. USA 97, 5263.
2. Basile, A.S., K. Saito, H. Li and M.P. Heyes, 1995, The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy in animal models of fulminant hepatic failure, J. Neurochem. 64, 2607.
3. Basile, A.S., E.A. Jones and P. Skolnick, 1991, The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands, Pharmacol. Rev. 42, 27.
4. Bergquist, P.B.F., M.P. Heyes, M. Bugge and F. Bengtsson, 1995, Brain quinolinic acid in chronic hepatic encephalopathy, J. Neurochem. 65, 2235.
5. Carpenedo, R., A. Chiarugi, P. Russi, G. Lombardi, V. Caria, R. Pellicciari, L. Mattoli and F. Moroni, 1994, Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenic acid and have sedative and anticonvulsant activities, Neuroscience 61, 237.
6. Chiarugi, A., R. Carpenedo, M.T. Molina, L. Mattoli, R. Pellicciari and F. Moroni, 1995, Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase. J. Neurochem. 65, 1176-1183.
7. Chiarugi, A., R. Carpenedo and F. Moroni, 1996, Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase, J. Neurochem. 67, 692.
8. Cummings, M.G., H.J. James and P.B. Soeters, 1976, Regional brain studies of indoleamine metabolism in the rat in acute hepatic failure, J. Neurochem. 27, 741.
9. Curzon, G., B.D. Kantamaneni, J. Winch, A. Rojas-Bueno, I.M. Murray-Lyon and R. Williams, 1973, Plasma and brain tryptophan changes in experimental acute hepatic failure, J. Neurochem. 21, 137.
10. Fraser, C.L. and A.I. Arieff, 1985, Hepatic encephalopathy, N. Engl. J. Med. 313, 865.
11. Hirayama, C. 1971, Tryptophan metabolism in liver disease, Clin. Chim. Acta 32, 191.
12. Jones, E.A., D.E. Shafer, P. Ferenci and S.C. Pappas, 1984, The neurobiology of hepatic encephalopathy, Hepatology 4, 1235.
13. Jones, E.A., C. Yurdaydin, A.S. Basile, J.E. Maddison, W.E. Watson, G.A. Johnston, C.H. Dejong, N.B. Deutz, P.B. Soeters, V. Felipo, E. Grau, M.D. Minana, S. Grisolia, K.D. Mullen, Z.Q. Gu, G. Nowak, C. Fromm, A.G. Holt, D.B. Jones, A. Puspok, A. Herneth, P. Steindl, P. Ferenci, S. Sarhan, B. Knodgen, C. Grauffel, N. Seiler and S. Sherlock, 1993, The GABA hypothesis - state of the art Glutamatergic neurotransmission in hepatic encephalopathy. Adv. Intern. Med. 38, 245.
14. 14C]indole in the rat, Biochem. J. 98, 266.
15. 3 receptors in N1E-115 neurpblastoma cells, Dr. J. Pharmacol. 112, 541.